Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 114   

Articles published

NVO 55.30 -0.33 (-0.59%)
price chart
Novo Nordisk A/S ADR. NYSE: NVO. GO. Set Alerts · Find a Broker · Join TD Ameritrade · Market Index · Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.
Why American Airlines Group Inc (AAL), Novo Nordisk A/S (ADR) (NVO) and ...
Why American Airlines Group Inc (AAL), Novo Nordisk A/S (ADR It could have been worse though - you could have owned a stake in American Airlines Group Inc (NASDAQ:AAL), Novo Nordisk A/S (ADR) (NYSE:NVO) or Synchrony Financial (NYSE:SYF).
Lesson Learned: Don't Trust Twitter Users With A Multi-Billion-Dollar Secret  Benzinga
Shares of Novo Nordisk A/S (NYSE:NVO) Sees Large Inflow of Net Money Flow  Market Digest
Novo Nordisk A/S (ADR) (NYSE:NVO) Victoza Reduces Cardiovascular Risks
Recent findings show that Victoza, a diabetes drug marketed by diabetes leader Novo Nordisk A/S (ADR) (NYSE:NVO) is the second diabetes drug that can significantly decrease cardiovascular risks among type 2 diabetes patients.
Novo Nordisk: Diabetes Pill Saves the Day  Business Finance News
Novo Nordisk A/S (ADR): Diabetic Leader Gets Yet Another FDA Approval
Despite the concerns raised by Food and Drug Administration (FDA) members regarding the Novo Nordisk A/S (NYSE:NVO) anti-diabetic molecule IDegLira's study design, FDA Endocrinology and Metabolic Drug Advisory Committee has given approval with ...
Novo Nordisk A/S (ADR) Rises on FDA Panel's Positive Vote for Diabetes Combo  Bidness ETC
HC Stocks News Ring: Amgen, Inc. (NASDAQ:AMGN), Novo Nordisk A/S (ADR) (NYSE:NVO)
Shares of Amgen, Inc. (NASDAQ:AMGN) ended Thursday session in green amid volatile trading. The shares closed up +0.94 points or 0.58% at $164.19 with 1.97 million shares getting traded.
Stock to Watch: Novo Nordisk A/S (ADR) (NYSE:NVO)
The shares of Novo Nordisk A/S (ADR) (NYSE:NVO) currently has mean rating of 1.00 while 1analysts have recommended the shares as “BUY”, Zero recommended as “OUTPERFORM” and Zero recommended as “HOLD”.
Novo Nordisk A/S (ADR) (NYSE:NVO) Plans To Spend Another $110 Million To ...
Apart from the upcoming construction of a new plant in the U.S, Novo Nordisk A/S (ADR) (NYSE:NVO), will also put together another more than $110 million for further expansion of its existing 31,000-square-meter site in Chartres in Europe.
Novo Nordisk A/S (ADR) Stock Surges On Increased Profit And Sales
Novo Nordisk A/S (ADR) (NYSE:NVO) announced its earnings for the first quarter of 2015 and the financial guidance for the full year 2015, and said that its current chief executive officer, Lars Rebien Sorensen, will remain at the helm of the company ...
Novo Nordisk CFO: U.S. Obesity Market Must Emerge, But It Will Take Time  Benzinga
Novo Nordisk profit rises; raises 2015 outlook  MarketWatch
Novo Nordisk A/S (ADR) Application For Insulin Drug Tresiba Accepted By FDA
Novo Nordisk A/S (ADR) (NYSE:NVO) has yet another victory to add to its long established success story in the diabetes market.
Is Novo Nordisk A/S (ADR) (NVO) Going to Burn These Hedge Funds?
Of the funds tracked by Insider Monkey, Renaissance Technologies holds the number one position in Novo Nordisk A/S (ADR) (NYSE:NVO). Renaissance Technologies has a $714.4 million position in the stock, comprising 1.7% of its 13F portfolio. Coming in ...